Conditions Archive - Page 2 of 3 - SOMAÍ Pharmaceuticals

Post-herpetic Neuralgia (PHN) and Medical Cannabis

Post-herpetic Neuralgia (PHN) is a chronic neuropathic pain condition that can last for months or even years after an episode...

Parkinson Disease and Medical Cannabis

Parkinson Disease (PD) is the most common neurodegenerative movement disorder and second neurodegenerative disorder after Alzheimer’s, affecting between 2-3 %...

Obsessive–compulsive disorder (OCD) and Medical Cannabis

Obsessive–compulsive disorder (OCD) is the key example of a set of conditions known as obsessive-compulsive and related disorders, a group...

Neuropathic Pain And Medical Cannabis

Pain is described as “An unpleasant sensory and emotional experience associated with actual or potential tissue damage” (Raja et al.,...

Multiple Sclerosis and Medical Cannabis

Multiple sclerosis (MS) is an autoimmune and neurologic disease affecting central nervous system (CNS) that results from an immune attack...

Migraine

Migraine is described as a complex disorder causing moderate to severe headaches, generally unilateral and associated with nausea and sensitivity...

Huntington’s disease and Medical Cannabis

Huntington’s disease (HD) is a neurodegenerative condition with a hereditary autosomal dominant genetic origin that causes nerve cells in the...

Epilepsy and seizure disorders

Epilepsy ranks among the most prevalent neurological diseases. It is estimated that about 50 million people are diagnosed with epilepsy....

Chronic Traumatic Encephalopathy and Cannabis

Chronic traumatic encephalopathy, henceforth abbreviated to CTE, is a progressive neurodegeneration often associated with contact sports. Firstly reported in 1928...